Stomatology Center of Gansu Provincial Hospital, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Bone density test room of Gansu Provincial Hospital, Gansu Provincial Hospital, Lanzhou, Gansu, China.
BMJ Open. 2021 Sep 13;11(9):e049277. doi: 10.1136/bmjopen-2021-049277.
Periodontal disease and osteoporosis are common chronic diseases, especially for the postmenopausal women. Several original studies explore the association, but there still controversial. Therefore, we will conduct this systematic review and meta-analysis to assess the association between periodontal disease and osteoporosis in postmenopausal women.
This study adheres to the Preferred Reporting Items for Systematic Reviews and Meta-analyses for Protocols. We will systematically search Medline/PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science and Scopus from inception to August 2021 to collect all relevant publications, with no restrictions on publication date or languages. Study selection, data extraction and risk of bias assessment will be conducted independently by two trained reviewers independently. The Cochrane's tool for assessing risk of bias, Newcastle-Ottawa Scale and Agency for Healthcare Research and Quality will be used for the risk of bias assessment. OR, HR and risk ratio with 95% CI were considered as the effect size for dichotomous outcomes, weighted mean difference with 95% CI were calculated as the effect size for continuous outcomes. Random-effects models will be used. Heterogeneity between studies will be assessed via the forest plot and I². Publication bias will detected by funnel plots, Begg's test and Egger's test. The subgroup analyses and sensitivity ananlyses will also be used to explore and interpret the heterogeneity.
This study does not require ethical approval. We will disseminate our findings by publishing results in a peer-reviewed journal.
CRD42021225746.
牙周病和骨质疏松症是常见的慢性疾病,尤其是绝经后妇女。有几项原始研究探讨了两者之间的关系,但仍存在争议。因此,我们将进行这项系统评价和荟萃分析,以评估绝经后妇女牙周病和骨质疏松症之间的关系。
本研究遵循系统评价和荟萃分析优先报告项目的议定书。我们将从成立到 2021 年 8 月,系统地搜索 Medline/PubMed、Embase、Cochrane 中央对照试验注册中心、Web of Science 和 Scopus,以收集所有相关出版物,对发表日期和语言不设限制。研究选择、数据提取和偏倚风险评估将由两名经过培训的评审员独立进行。Cochrane 工具用于评估偏倚风险,纽卡斯尔-渥太华量表和医疗保健研究与质量局用于评估偏倚风险。OR、HR 和风险比与 95%CI 被认为是二分类结局的效应量,加权均数差值与 95%CI 被计算为连续结局的效应量。将使用随机效应模型。通过森林图和 I²评估研究之间的异质性。通过漏斗图、贝格检验和埃格检验检测发表偏倚。还将进行亚组分析和敏感性分析,以探索和解释异质性。
本研究不需要伦理批准。我们将通过在同行评议的期刊上发表研究结果来传播我们的发现。
PROSPERO 注册号:CRD42021225746。